GO:0032680 regulation of tumor necrosis factor production: Biological Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032680 (regulation of tumor necrosis factor production) is a biological process that modulates the frequency, rate, or extent of TNF production, encompassing transcriptional, post-transcriptional, and secretory control [1,2].
• TNF production is regulated at multiple levels, including mRNA stability, membrane-bound precursor processing, and feedback loops involving the 26 kD membrane-bound TNF precursor [2,5].
• Key regulators include adrenergic agonists, which can suppress TNF production via beta-adrenergic receptors, and post-transcriptional mechanisms that downregulate TNF in acute infections.
• Dysregulation of TNF production is implicated in inflammatory diseases, including intestinal inflammation, sepsis, and chronic inflammatory conditions [1,4].
• Macrophages are central producers of TNF, and their TNF signaling pathways are critical for immune responses and disease pathogenesis.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of genes controlling TNF production for therapeutic target discovery.
Description
Tumor necrosis factor (TNF) is a pleiotropic cytokine that plays a central role in inflammation, immunity, and host defense. The regulation of its production is a tightly controlled biological process that ensures appropriate TNF levels while preventing excessive inflammation. GO:0032680, regulation of tumor necrosis factor production, encompasses any process that modulates the frequency, rate, or extent of TNF production. This includes transcriptional regulation, post-transcriptional modifications such as mRNA stability, and the processing of membrane-bound TNF precursor to soluble TNF [2,5]. Understanding this process is critical because both insufficient and excessive TNF production contribute to disease. For example, dysregulated TNF production is a hallmark of chronic inflammatory diseases, including inflammatory bowel disease and rheumatoid arthritis [1,4]. Moreover, post-transcriptional downregulation of TNF has been observed in acute meningococcal infections, highlighting the clinical relevance of these regulatory mechanisms. Researchers studying GO:0032680 aim to identify the molecular players and pathways that control TNF levels, with the goal of developing targeted therapies. This article provides a comprehensive overview of the definition, mechanisms, key genes, and research methods associated with this GO term, based on authoritative QuickGO data and verified PubMed literature.
regulation of tumor necrosis factor production At A Glance
| GO ID | GO:0032680 |
|---|---|
| GO term | regulation of tumor necrosis factor production |
| Ontology | biological_process |
| Synonym | regulation of cachectin production; regulation of TNF-alpha production; regulation of TNF production; regulation of tumor necrosis factor-alpha production; regulation of tumor necrosis factor biosynthetic process; regulation of tumor necrosis factor secretion |
| Major function | Modulates the frequency, rate, or extent of TNF production, impacting inflammation and immune responses. |
| Related processes | TNF biosynthesis, TNF secretion, inflammatory response, immune regulation. |
| Cellular location | Cytoplasm, endoplasmic reticulum, Golgi, plasma membrane (for membrane-bound TNF). |
| Key regulators | Adrenergic agonists, post-transcriptional factors, membrane-bound TNF precursor. |
| Disease relevance | Inflammatory diseases, sepsis, autoimmune disorders, cancer. |
What Is GO:0032680?
According to the Gene Ontology, GO:0032680 (regulation of tumor necrosis factor production) is defined as any process that modulates the frequency, rate, or extent of tumor necrosis factor production. This includes regulation of TNF-alpha production, cachectin production, and TNF biosynthetic and secretion processes. In essence, it covers all molecular events that control how much TNF is made and released by cells, whether at the level of gene transcription, mRNA translation, protein processing, or secretion.
Why Is regulation of tumor necrosis factor production Important in Cell Biology?
Regulation of TNF production is a cornerstone of immune homeostasis and inflammation. TNF is a master cytokine that orchestrates the acute phase response, immune cell recruitment, and pathogen clearance. However, when TNF production is not properly regulated, it can lead to chronic inflammation, tissue damage, and autoimmune diseases. Therefore, understanding the mechanisms that control TNF production is essential for developing therapies that can either boost or dampen TNF levels as needed. This process is also a target for anti-inflammatory drugs, such as anti-TNF biologics, which are used to treat conditions like rheumatoid arthritis and inflammatory bowel disease [1,4]. Moreover, the post-transcriptional regulation of TNF, as seen in acute infections, offers potential targets for modulating the immune response.
• TNF is a key mediator of inflammation and immune responses, and its production must be tightly regulated.
• Dysregulated TNF production is implicated in chronic inflammatory diseases such as inflammatory bowel disease and rheumatoid arthritis [1,4].
• Post-transcriptional mechanisms, including mRNA stability, are critical for rapid changes in TNF levels during infection [2,7].
• Adrenergic agonists can suppress TNF production, linking the nervous system to immune regulation.
• The membrane-bound TNF precursor can feedback-regulate its own production, demonstrating autoregulatory loops.
• Macrophages are major producers of TNF, and their regulation is central to innate immunity.
• TNF production is a target for therapeutic intervention in sepsis and acute infections.
• Understanding TNF regulation can inform the development of CRISPR-based cell models for drug discovery.
• TNF also regulates other processes, such as vitamin D production in keratinocytes, showing its pleiotropic effects.
• Research on GO:0032680 can uncover novel regulatory nodes for precision medicine.
What Happens During regulation of tumor necrosis factor production?
Transcriptional Control of TNF Gene Expression
In simple terms: The first step in making TNF is turning on the TNF gene to produce mRNA.
TNF production begins with transcription of the TNF gene, which is tightly regulated by transcription factors such as NF-kB and AP-1 in response to inflammatory stimuli. This transcriptional control determines the initial burst of TNF mRNA. However, transcriptional regulation alone does not account for the rapid changes in TNF levels observed during inflammation; post-transcriptional mechanisms also play a major role.
Post-transcriptional Regulation of TNF mRNA
In simple terms: After mRNA is made, its stability and translation can be controlled to adjust TNF levels quickly.
Post-transcriptional regulation is critical for modulating TNF production. The 3' untranslated region of TNF mRNA contains AU-rich elements that regulate its stability and translation. Proteins that bind these elements can either stabilize or destabilize the mRNA, thereby affecting how much TNF protein is produced. For instance, in acute meningococcal infections, TNF-alpha production is downregulated post-transcriptionally, highlighting the importance of this level of control [2,7].
Processing and Secretion of TNF
In simple terms: TNF is initially made as a membrane-bound precursor that must be cut to release the active soluble form.
TNF is synthesized as a 26 kD membrane-bound precursor (mTNF) that is displayed on the cell surface. This precursor can be cleaved by the enzyme TACE (ADAM17) to release the soluble 17 kD form (sTNF). The membrane-bound precursor can also signal to neighboring cells and even feedback to regulate its own production. The balance between membrane-bound and soluble TNF is crucial for its biological activities.
Feedback Regulation by Membrane-bound TNF
In simple terms: The membrane-bound form of TNF can act back on the cell to control how much more TNF is made.
The 26 kD membrane-bound TNF precursor can mediate bidirectional feedback regulation on TNF production. Studies have shown that mTNF can downregulate its own production, possibly through interactions with receptors on the same or adjacent cells. This autoregulatory loop prevents excessive TNF production and maintains immune homeostasis.
Neuroendocrine and Pharmacological Modulation
In simple terms: Signals from the nervous system, such as adrenaline, can turn down TNF production.
TNF production is subject to neuroendocrine regulation. Adrenaline and beta-adrenergic agonists have been shown to suppress TNF production, likely through beta-adrenergic receptors on immune cells. This provides a link between the sympathetic nervous system and immune regulation, and suggests that stress or pharmacological agents can modulate TNF levels.
Key Genes Involved in GO:0032680 regulation of tumor necrosis factor production
The following genes and proteins are key players in the regulation of TNF production, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNF | Encodes tumor necrosis factor, the cytokine whose production is regulated. | Central to studies of GO:0032680; target for knockout and knock-in models. |
| NFKB1 | Transcription factor that drives TNF gene expression. | Knockout studies reveal its role in inflammatory responses. |
| REL | NF-kB subunit that regulates TNF transcription. | Potential target for modulating TNF in autoimmune diseases. |
| MAPK14 | Kinase involved in signaling pathways that control TNF production. | Inhibitors are studied for anti-inflammatory effects. |
| ADAM17 | Enzyme that cleaves membrane-bound TNF to release soluble TNF. | Knockout models show impaired TNF secretion. |
| TNFRSF1A | Receptor for TNF, mediates feedback regulation. | Knockout mice are used to study TNF signaling. |
| TNFRSF1B | Receptor for TNF, involved in immune regulation. | Contributes to TNF-mediated effects in various tissues. |
| IL10 | Anti-inflammatory cytokine that suppresses TNF production. | Knockout models exhibit excessive TNF production. |
| TLR4 | Pattern recognition receptor that triggers TNF production. | Target for sepsis research. |
| MYD88 | Adaptor protein in TLR signaling leading to TNF production. | Knockout mice are resistant to endotoxin shock. |
| IRAK1 | Kinase in TLR/IL-1R signaling that regulates TNF. | Inhibitors are explored for inflammatory diseases. |
| TRAF6 | E3 ligase in NF-kB activation and TNF production. | Knockout studies show impaired immune responses. |
| NLRP3 | Inflammasome component that can influence TNF production. | Linked to autoinflammatory diseases. |
| CASP1 | Caspase-1 processes IL-1beta and can affect TNF levels. | Inhibitors are studied in inflammation. |
| PTPN22 | Phosphatase that modulates immune signaling and TNF. | Associated with autoimmune diseases. |
| TNFAIP3 | Feedback inhibitor of NF-kB and TNF production. | Knockout mice develop severe inflammation. |
| ZFPM1 | Transcription factor that can regulate TNF expression. | Emerging role in immune regulation. |
| ELAVL1 | RNA-binding protein that stabilizes TNF mRNA. | Knockdown reduces TNF production. |
How Is regulation of tumor necrosis factor production Regulated?
The regulation of TNF production is a complex process involving multiple layers of control. At the transcriptional level, NF-kB and MAP kinases are activated by pattern recognition receptors such as TLR4, leading to TNF gene transcription. Post-transcriptionally, RNA-binding proteins such as ELAVL1 (HuR) can stabilize TNF mRNA, while others promote its degradation. The membrane-bound TNF precursor can feedback to inhibit its own production, possibly through reverse signaling. Additionally, neuroendocrine factors like adrenaline can suppress TNF production via beta-adrenergic receptors. Anti-inflammatory cytokines such as IL-10 also downregulate TNF production. These regulatory mechanisms ensure that TNF is produced transiently and locally, preventing systemic toxicity.
regulation of tumor necrosis factor production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNF | Inflammatory bowel disease, rheumatoid arthritis | Knockout mice, human intestinal organoids |
| TNFAIP3 | Autoimmune diseases, lymphoma | Knockout cell lines, mouse models |
| IL10 | Inflammatory bowel disease | Knockout mice, patient-derived macrophages |
| ADAM17 | Inflammatory skin diseases, cancer | Conditional knockout mice, 3D skin models |
| TNFRSF1A | Periodic fever syndrome | Knock-in mice, patient fibroblasts |
Inflammatory Bowel Disease
Dysregulated TNF production is a hallmark of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Excessive TNF in the intestinal mucosa leads to chronic inflammation and tissue damage. Anti-TNF therapies are widely used to treat IBD, underscoring the importance of understanding the regulation of TNF production.
Sepsis and Acute Infections
In sepsis, an exaggerated immune response triggers massive TNF production, leading to systemic inflammation and organ failure. Post-transcriptional downregulation of TNF has been observed in acute meningococcal infections, suggesting that the body attempts to counteract excessive TNF. Studying these mechanisms could reveal new therapeutic targets for sepsis.
Autoimmune Diseases
TNF is a key mediator in autoimmune diseases such as rheumatoid arthritis and psoriasis. Genetic variants in genes regulating TNF production, such as TNFAIP3, are associated with autoimmune conditions. Modulating TNF production through CRISPR-based approaches could provide new treatment strategies.
Cancer
TNF can have dual roles in cancer, promoting tumor growth and survival in some contexts while inducing apoptosis in others. The regulation of TNF production in the tumor microenvironment influences cancer progression and response to immunotherapy. Understanding these regulatory mechanisms is crucial for developing TNF-based cancer therapies.
From regulation of tumor necrosis factor production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate TNF production? | CRISPR knockout in macrophage cell lines (e.g., THP-1, RAW264.7) |
| How does a point mutation in gene Y affect TNF production? | CRISPR point mutation knock-in in primary immune cells |
| What is the effect of overexpressing gene Z on TNF levels? | Lentiviral overexpression in epithelial cells |
| Where is gene W expressed during inflammation? | Tagged knock-in reporter mice |
| Can we screen for novel regulators of TNF production? | Genome-wide CRISPR library screening in TNF reporter cells |
| How does a disease-associated SNP affect TNF regulation? | CRISPR knock-in of SNP in patient-derived iPSCs |
How to Study the regulation of tumor necrosis factor production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | TNF mRNA levels and transcriptome changes | Identifying transcriptional regulators of TNF |
| Ribo-seq | Translation efficiency of TNF mRNA | Studying post-transcriptional control |
| ELISA | Soluble TNF protein concentration | Quantifying TNF secretion in cell culture |
| Flow cytometry | Membrane-bound TNF on cell surface | Analyzing TNF precursor processing |
| CRISPR screen | Genes affecting TNF production | High-throughput discovery of regulators |
| RIP-seq | RNA-protein interactions | Identifying RNA-binding proteins on TNF mRNA |
| Western blot | TNF protein isoforms | Detecting membrane-bound and soluble TNF |
Transcriptional Profiling
RNA-seq and microarray can measure TNF mRNA levels under various conditions, providing insights into transcriptional regulation. These methods are often used in combination with CRISPR knockouts to identify genes controlling TNF transcription.
Post-transcriptional Analysis
Ribo-seq and polysome profiling can assess translation efficiency of TNF mRNA. RNA immunoprecipitation (RIP) can identify RNA-binding proteins that interact with TNF mRNA, revealing post-transcriptional regulatory mechanisms [2,7].
Protein Quantification
ELISA and Western blot are standard methods to measure soluble and membrane-bound TNF protein levels. Flow cytometry can detect membrane-bound TNF on the cell surface, which is important for understanding precursor processing.
Functional Genomics
CRISPR screens with TNF reporters can identify novel regulators of TNF production. These screens typically use fluorescent or luminescent reporters driven by the TNF promoter, enabling high-throughput identification of genes that modulate TNF expression.
How CRISPR Can Be Used to Study GO:0032680 regulation of tumor necrosis factor production
Knockout
CRISPR knockout of candidate genes in macrophage cell lines can determine whether they are required for TNF production. For example, knocking out TLR4 or MYD88 abolishes LPS-induced TNF production, confirming their essential roles.
Point Mutation
Introducing point mutations in regulatory regions of the TNF gene or in genes encoding signaling proteins can reveal how specific amino acids or nucleotides affect TNF production. This is particularly useful for studying disease-associated SNPs.
Knock-in
Knock-in of reporter genes (e.g., GFP) into the TNF locus allows real-time monitoring of TNF promoter activity. Alternatively, knocking in epitope tags on regulatory proteins enables their functional analysis.
Overexpression
Overexpressing candidate genes using lentiviral vectors can test whether increased levels of a protein enhance or suppress TNF production. This approach is valuable for studying gain-of-function mutations.
How EDITGENE Supports regulation of tumor necrosis factor production Research
Researchers studying regulation of tumor necrosis factor production-related genes often need to determine whether a candidate gene is causally involved in controlling TNF levels. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of tumor necrosis factor production research.
Frequently Asked Questions About regulation of tumor necrosis factor production
What is GO:0032680?
GO:0032680 is a Gene Ontology term for 'regulation of tumor necrosis factor production', defined as any process that modulates the frequency, rate, or extent of TNF production.
What genes are involved in regulation of tumor necrosis factor production?
Key genes include TNF, NFKB1, ADAM17, TLR4, MYD88, and TNFAIP3, among others, which control transcription, processing, and feedback of TNF [1,2,5,6].
How is TNF production regulated post-transcriptionally?
TNF mRNA stability and translation are controlled by AU-rich elements and RNA-binding proteins, allowing rapid changes in TNF levels [2,7].
What is the role of membrane-bound TNF in regulation?
The 26 kD membrane-bound TNF precursor can feedback to regulate its own production and can be cleaved to release soluble TNF.
Can adrenaline affect TNF production?
Yes, adrenaline and beta-adrenergic agonists can suppress TNF production via beta-adrenergic receptors.
What diseases are associated with dysregulated TNF production?
Inflammatory bowel disease, rheumatoid arthritis, sepsis, and autoimmune diseases are linked to abnormal TNF regulation [1,4,7].
How can CRISPR be used to study TNF regulation?
CRISPR knockout, knock-in, and overexpression models allow precise manipulation of genes to study their effects on TNF production.
What methods measure TNF production?
ELISA, flow cytometry, RNA-seq, and Ribo-seq are commonly used to measure TNF mRNA and protein levels [2,5].
What is the difference between soluble and membrane-bound TNF?
Soluble TNF (17 kD) is cleaved from membrane-bound TNF (26 kD) by ADAM17; both forms have distinct biological activities.
How does IL-10 regulate TNF production?
IL-10 is an anti-inflammatory cytokine that suppresses TNF production, and its knockout leads to excessive inflammation.
Conclusion
The regulation of tumor necrosis factor production (GO:0032680) is a critical biological process that controls a central mediator of inflammation. Dysregulation of this process contributes to a wide range of diseases, from chronic inflammatory conditions to acute infections. Understanding the molecular mechanisms, key genes, and regulatory pathways involved is essential for developing targeted therapies. Advances in CRISPR-based models and functional genomics are accelerating the discovery of novel regulators of TNF production, offering new opportunities for therapeutic intervention. EDITGENE's comprehensive services support researchers in dissecting these mechanisms with precision and scale.
References
- 1. Gubernatorova EO et al.. 2016. Tumor Necrosis Factor and Lymphotoxin in Regulation of Intestinal Inflammation.. Biochemistry (Mosc) 81(11):1309-1325 PMID: 27914457
- 2. Anderson P. 2000. Post-transcriptional regulation of tumour necrosis factor alpha production.. Ann Rheum Dis 59 Suppl 1(Suppl 1):i3-5 PMID: 11053078
- 3. Severn A et al.. 1992. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists.. J Immunol 148(11):3441-5 PMID: 1350291
- 4. Hide I. 2003. [Mechanism of production and release of tumor necrosis factor implicated in inflammatory diseases].. Nihon Yakurigaku Zasshi 121(3):163-73 PMID: 12673950
- 5. Soma IG et al.. 1995. Bidirectional feedback regulation on 17 kD tumor necrosis factor (TNF) production by 26 kD membrane-bound TNF precursor.. J Inflamm 47(1-2):52-60 PMID: 8913929
- 6. Parameswaran N et al.. 2010. Tumor necrosis factor-α signaling in macrophages.. Crit Rev Eukaryot Gene Expr 20(2):87-103 PMID: 21133840
- 7. van Deuren M et al.. 1998. Posttranscriptional down-regulation of tumor necrosis factor-alpha and interleukin-1beta production in acute meningococcal infections.. J Infect Dis 177(5):1401-5 PMID: 9593034
- 8. Bikle DD et al.. 1991. Tumor necrosis factor-alpha regulation of 1,25-dihydroxyvitamin D production by human keratinocytes.. Endocrinology 129(1):33-8 PMID: 1675987
